Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Merck & Co Inc MRK

Healthcare
Merck & Co., Inc. is a global health care company. It offers health solutions through its prescription medicines, including biologic therapies, vaccines and animal health products. Its Pharmaceutical segment includes human health pharmaceuticals and vaccine products. Human health pharmaceutical products include therapeutic and preventive agents, sold by prescription, for the treatment of human... see more

Recent & Breaking News (NYSE:MRK)

Merck’s Fight Against Infectious Disease Goes Digital with Launch of ILÚM Health Solutions

Business Wire February 16, 2017

Merck Still Sees Path Forward For Failed Alzheimer's Drug

Benzinga.com  February 15, 2017

Deutsche Bank Casts Doubt On Pfizer's Rumored Takeover Approach To Bristol-Myers

Benzinga.com  February 15, 2017

Merck Announces EPOCH Study of Verubecestat for the Treatment of People with Mild to Moderate Alzheimer’s Disease to Stop for Lack of Efficacy

Business Wire February 14, 2017

Merck’s Doravirine, an Investigational Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) for the Treatment of HIV-1 Infection, Met Primary Efficacy Endpoint in Pivotal Phase 3 Trial

Business Wire February 14, 2017

Merck Foundation Announces Six Program Grant Recipients for Alliance to Advance Patient-Centered Cancer Care

Business Wire February 9, 2017

Newly released option reports for Boston Scientific Corporation, Cirrus Logic, Merck & Company Incorporated, Charles Schwab and Wells Fargo & Co.

PR Newswire February 3, 2017

FDA Accepts Two sBLAs for Merck’s KEYTRUDA® (pembrolizumab) for Locally Advanced or Metastatic Urothelial Cancer in Cisplatin-Ineligible First-Line and Second-Line Post-Platinum Failure Treatment Settings

Business Wire February 3, 2017

Merck Announces Fourth-Quarter and Full-Year 2016 Financial Results

Business Wire February 2, 2017

Earnings: Facebook and Merck Scheduled to Open Their Books

Benzinga.com  February 1, 2017

Ringing up the iPhones: Strong Apple Results Put A Charge Into Markets

Benzinga.com  February 1, 2017

European Commission Approves KEYTRUDA® (pembrolizumab) for First-Line Treatment of Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC) Whose Tumors Have High PD-L1 Expression with No EGFR or ALK Positive Tumor Mutations

Business Wire January 31, 2017

Pro Football Hall of Famer and Cancer Survivor Jim Kelly Teams Up with Merck and Leading Cancer Organizations to Launch Your Cancer Game Plan

Business Wire January 25, 2017

Merck Announces Settlement and License Agreement Resolving KEYTRUDA® (pembrolizumab) Patent Litigation

Business Wire January 20, 2017

Wall Street's M&A Chatter From January 19

Benzinga.com  January 20, 2017

Merck and Genea Open Centre of Excellence for Fertility

PR Newswire Europe Non Regulatory January 20, 2017

MSD for Mothers Commits $10 Million and Business Expertise to the Global Financing Facility to Help End Preventable Deaths of Mothers

Business Wire January 19, 2017

Merck Foundation Grant Expands Project ECHO® in Vietnam and India

Business Wire January 18, 2017

Technical Reports on Drug Makers Stocks -- Pfizer, Merck, AbbVie, and Johnson & Johnson

PR Newswire January 18, 2017

Favorable News On Keytruda Drives Piper Jaffray's Upgrade Of Merck

Benzinga.com  January 12, 2017
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse
Later
Participate
Not interested